12 days ago
MRK
AnalystsGeoff MeachamGeoff Meacham's Stock Forecasts
AnalystsGeoff Meacham
Analyst Ranking
Top 11%
#531 out of 5192 analysts
Average Return
+7.71%
Win Rate
56%101 out of 181
Risk vs Reward
Poor
Good
Geoff Meacham's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | +164.92% | $5.33 | $14.12 | 2025-06-17 - 2026-02-13 | Strong Buy |
Bridgebio Pharma IncBBIO | +161.09% | $27.19 | $70.99 | 2024-11-25 - 2025-11-24 | Strong Buy |
Coherent CorpCOHR | +150.48% | $26.29 | $65.85 | 2020-03-23 - 2021-03-23 | Strong Buy |
Kymera Therapeutics IncKYMR | +146.16% | $33.45 | $82.34 | 2025-03-13 - 2026-02-13 | Strong Buy |
Checkmate Pharmaceuticals IncCMPI | +144.76% | $4.29 | $10.50 | 2021-10-06 - 2022-05-27 | Strong Buy |
Geoff Meacham Analyst Color
Get additional color on Geoff Meacham's coverage of popular stocks
20 days ago
GILD
20 days ago
MRK
20 days ago
RPRX
2 months ago
PTGX
4 months ago
PTGX
4 months ago
NAMS
4 months ago
KYMR
4 months ago
KNSA
4 months ago
AMLX
4 months ago
GILD
4 months ago
AMLX
4 months ago
VRTX
9 months ago
ABBV
a year ago
LLY
2 years ago
LLY
2 years ago
LLY
2 years ago
LLY
3 years ago
MRNA
3 years ago
LLY
3 years ago
PFE
3 years ago
MRK
3 years ago
PFE
4 years ago
MRNA
4 years ago
PFE
Geoff Meacham's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biogen IncBIIB | 17 | Hold | $215.00 | +9.40% | Maintains | 7 days ago |
Bristol Myers Squibb CoBMY | 8 | Hold | $64.00 | +5.37% | Maintains | 10 days ago |
Merck & Co IncMRK | 11 | Hold | $120.00 | -1.16% | Maintains | 12 days ago |
Amgen IncAMGN | 12 | Hold | $345.00 | -6.55% | Maintains | 12 days ago |
Abbvie IncABBV | 22 | Hold | $230.00 | -0.65% | Maintains | 20 days ago |
Gilead Sciences IncGILD | 9 | Strong Buy | $156.00 | +0.66% | Maintains | 20 days ago |
Royalty Pharma PLCRPRX | 4 | Strong Buy | $50.00 | +10.64% | Maintains | 20 days ago |
Scholar Rock Holding CorpSRRK | 1 | Strong Buy | $55.00 | +19.62% | Initiates Coverage On | a month ago |
Vor Biopharma IncVOR | 1 | Strong Buy | $50.00 | +291.24% | Initiates Coverage On | a month ago |
Kymera Therapeutics IncKYMR | 7 | Strong Buy | $110.00 | +33.59% | Maintains | 2 months ago |
Protagonist Therapeutics IncPTGX | 4 | Strong Buy | $115.00 | +41.12% | Maintains | 2 months ago |
Janux Therapeutics IncJANX | 3 | Strong Buy | $49.00 | +272.91% | Maintains | 2 months ago |
Pfizer IncPFE | 7 | Hold | $26.00 | -5.73% | Reinstates | 2 months ago |
Acumen Pharmaceuticals IncABOS | 6 | Strong Buy | $8.00 | +218.73% | Maintains | 3 months ago |
Ptc Therapeutics IncPTCT | 10 | Hold | $75.00 | +7.99% | Maintains | 3 months ago |
Regeneron Pharmaceuticals IncREGN | 11 | Strong Buy | $700.00 | -12.85% | Maintains | 4 months ago |
Avidity Biosciences IncRNA | 8 | Hold | $72.00 | -1.19% | Downgrades | 4 months ago |
Moderna IncMRNA | 8 | Hold | $28.00 | -33.70% | Maintains | 4 months ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $50.00 | +44.38% | Maintains | 4 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 4 | Strong Buy | $50.00 | +10.20% | Maintains | 4 months ago |
Amylyx Pharmaceuticals IncAMLX | 5 | Strong Buy | $20.00 | +41.64% | Maintains | 4 months ago |
Crispr Therapeutics AgCRSP | 4 | Strong Buy | $93.00 | +75.24% | Maintains | 4 months ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $575.00 | +17.00% | Maintains | 4 months ago |
Vir Biotechnology IncVIR | 3 | Strong Buy | $14.00 | +87.42% | Upgrades | 6 months ago |
Bridgebio Pharma IncBBIO | 6 | Strong Buy | $54.00 | -28.24% | Maintains | 8 months ago |
Arcellx IncACLX | 1 | Strong Buy | $110.00 | +60.58% | Initiates Coverage On | 8 months ago |
Novavax IncNVAX | 1 | Strong Sell | $6.00 | -31.03% | Initiates Coverage On | 8 months ago |
Biontech SeBNTX | 2 | Strong Buy | $140.00 | +32.24% | Maintains | 9 months ago |
Neumora Therapeutics IncNMRA | 3 | Sell | $1.00 | -68.75% | Downgrades | 10 months ago |
Apogee Therapeutics IncAPGE | 2 | Strong Buy | $95.00 | +40.16% | Initiates Coverage On | a year ago |
89bio IncETNB | 1 | Strong Buy | $25.00 | +68.46% | Initiates Coverage On | a year ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $103.00 | +72.04% | Maintains | a year ago |
Bioxcel Therapeutics IncBTAI | 5 | Sell | $4.00 | N/A | Downgrades | a year ago |
Eli Lilly & CoLLY | 10 | Strong Buy | $1,100.00 | N/A | Maintains | a year ago |
Lyell Immunopharma IncLYEL | 3 | Sell | $20.00 | N/A | Downgrades | a year ago |
Tyra Biosciences IncTYRA | 2 | Strong Buy | $31.00 | N/A | Upgrades | a year ago |
Turnstone Biologics CorpTSBX | 2 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Johnson & JohnsonJNJ | 2 | Hold | $170.00 | N/A | Maintains | 2 years ago |
LianbioLIANY | 1 | Sell | $3.00 | N/A | Downgrades | 2 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $8.00 | N/A | Downgrades | 2 years ago |
Curevac NvCVAC | 4 | Sell | $8.00 | N/A | Maintains | 2 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Intercept Pharmaceuticals IncICPT | 5 | Sell | $14.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 3 | Sell | $2.00 | N/A | Downgrades | 3 years ago |
Inovio Pharmaceuticals IncINO | 4 | Sell | $24.00 | N/A | Downgrades | 3 years ago |
Omeros CorpOMER | 2 | Hold | $4.00 | N/A | Downgrades | 4 years ago |
Vaxxinity IncVAXX | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 4 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $7.00 | N/A | Upgrades | 4 years ago |
Erasca IncERAS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Strong Buy | $56.00 | N/A | Upgrades | 5 years ago |
Esperion Therapeutics IncESPR | 2 | Hold | $35.00 | N/A | Downgrades | 5 years ago |
Seagen IncSGEN | 6 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Galecto IncGLTO | 1 | Strong Buy | $525.00 | N/A | Initiates Coverage On | 5 years ago |
Pmv Pharmaceuticals IncPMVP | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 5 years ago |
Meiragtx Holdings PLCMGTX | 1 | Strong Buy | $20.00 | N/A | Reinstates | 5 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | $20.00 | N/A | Reinstates | 5 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Puma Biotechnology IncPBYI | 1 | Sell | $9.00 | N/A | Reinstates | 6 years ago |
Regenxbio IncRGNX | 1 | Strong Buy | $60.00 | N/A | Reinstates | 6 years ago |
Genfit SaGNFTY | 1 | Sell | $7.00 | N/A | Initiates Coverage On | 6 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $51.00 | N/A | Initiates Coverage On | 6 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $110.00 | N/A | Downgrades | 6 years ago |
United Therapeutics CorpUTHR | 2 | Strong Sell | $95.00 | N/A | Maintains | 7 years ago |
Myovant Sciences LtdMYOV | 2 | Strong Buy | $25.00 | N/A | Upgrades | 7 years ago |
Dbv Technologies SaDBVT | 3 | Hold | $80.00 | N/A | Downgrades | 7 years ago |
Gritstone Bio IncGRTSQ | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 7 years ago |
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $135.00 | N/A | Maintains | 8 years ago |
Prothena Corp Public Ltd CoPRTA | 2 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Zymeworks IncZYME | 2 | Hold | N/A | N/A | Upgrades | 8 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | $20.00 | N/A | Maintains | 8 years ago |
Incyte CorpINCY | 2 | Strong Buy | $135.00 | N/A | Maintains | 8 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | $54.00 | N/A | Maintains | 8 years ago |
Celgene CorpCELG | 4 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $158.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.